New HIV Vaccine Based On Moderna Shows Positive Results (refinery29.com)
> A new HIV vaccine, based on the Moderna COVID-19 inoculation, has shown a 97% antibody response rate in Phase I clinical trials.
Chúng mày nghĩ sao.
> A new HIV vaccine, based on the Moderna COVID-19 inoculation, has shown a 97% antibody response rate in Phase I clinical trials.
Chúng mày nghĩ sao.